QUILLIVANT ER ORAL SUSPENSION
Google image searchProduct monograph
Active ingredient
methylphenidate hydrochloride, 5 MG/ML
DIN: 02541637
Dosage form(s): POWDER (EXTENDED RELEASE)
Route(s) of administration: ORAL
Schedule: Schedule G (CDSA III)
Company: KYE PHARMACEUTICALS INC.
Date: 19-AUG-2024
ATC:
- N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
- N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
- N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
- N06BA04 — METHYLPHENIDATE (ATC/DDD)
Reference brand drug: Biphentin, Concerta, Ritalin
